Peter Sand to United States
This is a "connection" page, showing publications Peter Sand has written about United States.
Connection Strength
0.105
-
Urinary incontinence after multiple gestation and delivery: impact on quality of life. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct; 16(5):334-6.
Score: 0.027
-
The safety of reusing injectable collagen: a multicenter microbiological study. Int Urogynecol J Pelvic Floor Dysfunct. 2002; 13(4):232-4; discussion 235.
Score: 0.022
-
OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93.
Score: 0.012
-
Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns--positive reactions are possible. Int Urogynecol J. 2012 Jan; 23(1):11-3.
Score: 0.011
-
Nongenetic factors associated with stress urinary incontinence. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):251-255.
Score: 0.010
-
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther. 2006 Nov; 28(11):1935-46.
Score: 0.008
-
Perceptions and behaviours of women with bladder control problems. Fam Pract. 2006 Oct; 23(5):568-77.
Score: 0.007
-
Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol. 2002; 34(1):43-9.
Score: 0.005
-
Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women. Urology. 1997 Dec; 50(6):934-40.
Score: 0.004